5 results
6-K
EX-99.3
INCR
Intercure Ltd
3 Apr 23
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
8:00am
is currently advancing in the construction of the clinical trial in this channel for the treatment of chronic lymphocytic leukemia (CLL
20-F
2021 FY
INCR
Intercure Ltd
28 Apr 22
Annual report (foreign)
12:02pm
of the selected indication. Cavnox is currently advancing in the construction of the clinical trial in this channel for the treatment of chronic … of chronic lymphocytic leukemia (CLL) with a mutation in the Notch gene.
The second clinical channel is a pharmaceutical route which Cavnox will not use
6-K
EX-99.3
INCR
Intercure Ltd
7 Apr 22
Current report (foreign)
4:31pm
in the construction of the clinical trial in this channel for the treatment of chronic lymphocytic leukemia (CLL) with a mutation in the Notch gene.
The second
- Prev
- 1
- Next